Literature DB >> 12112523

Loss of heterozygosity analysis: practically and conceptually flawed?

Ian P M Tomlinson1, Maryou B K Lambros, Rebecca R Roylance.   

Abstract

The Knudson "two-hit" hypothesis has provided the rationale for studies that aim to identify tumor-suppressor genes by mapping regions of allelic loss (loss of heterozygosity, LOH). Although LOH has been found in practically all types of tumors, very few such projects have been successful in identifying their tumor-suppressor targets. The prime explanation for this failure is probably that researchers have, in general, been too credulous about the two-hit hypothesis, and too willing to ignore factors such as intratumor heterogeneity, contamination by normal cells, karyotypic complexity, homozygous deletions, gene dosage changes, and polymerase chain reaction artifacts. We suggest ways of minimizing these problems. Unfortunately, there is no guarantee that existing or newer methods, such as genomic microarrays and in situ single-nucleotide polymorphism analysis, will solve the difficulties of LOH analysis. The future prospects for LOH studies are, as ever, uncertain. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2002        PMID: 12112523     DOI: 10.1002/gcc.10085

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  22 in total

1.  Allelotyping for loss of heterozygosity on chromosome 18 in gastric cancer.

Authors:  Jing-Cui Yu; Kai-Lai Sun; Buo Liu; Song-Bin Fu
Journal:  World J Gastroenterol       Date:  2004-07-01       Impact factor: 5.742

Review 2.  Embryonic reversions and lineage infidelities in tumour cells: genome-based models and role of genetic instability.

Authors:  Leon P Bignold
Journal:  Int J Exp Pathol       Date:  2005-04       Impact factor: 1.925

3.  Epigenetic regulation of the tumor suppressor gene TCF21 on 6q23-q24 in lung and head and neck cancer.

Authors:  Laura T Smith; Mauting Lin; Romulo M Brena; James C Lang; David E Schuller; Gregory A Otterson; Carl D Morrison; Dominic J Smiraglia; Christoph Plass
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-13       Impact factor: 11.205

Review 4.  The roles of UVB and vitamin D in reducing risk of cancer incidence and mortality: A review of the epidemiology, clinical trials, and mechanisms.

Authors:  Meis Moukayed; William B Grant
Journal:  Rev Endocr Metab Disord       Date:  2017-06       Impact factor: 6.514

5.  hMLH1 and hMSH2 somatic inactivation mechanisms in sporadic colorectal cancer patients.

Authors:  Enikô Kámory; Orsolya Kolacsek; Szabolcs Ottó; Orsolya Csuka
Journal:  Pathol Oncol Res       Date:  2003-12-22       Impact factor: 3.201

6.  Single nucleotide polymorphism array analysis of microsatellite-stable, diploid/near-diploid colorectal carcinomas without the CpG island methylator phenotype.

Authors:  Michael Linnebacher; Christiane Ostwald; Dirk Koczan; Tareq Salem; Björn Schneider; Mathias Krohn; Mathias Ernst; Friedrich Prall
Journal:  Oncol Lett       Date:  2012-10-30       Impact factor: 2.967

Review 7.  Tumor heterogeneity: causes and consequences.

Authors:  Andriy Marusyk; Kornelia Polyak
Journal:  Biochim Biophys Acta       Date:  2009-11-18

8.  Methylation-specific multiplex ligation-dependent probe amplification in meningiomas.

Authors:  Christian Ewald; Thomas Hofmann; Susanne A Kuhn; Thomas Deufel; Christian Beetz; Rolf Kalff
Journal:  J Neurooncol       Date:  2008-09-02       Impact factor: 4.130

Review 9.  Large-scale genomic analysis of ovarian carcinomas.

Authors:  Kylie L Gorringe; Ian G Campbell
Journal:  Mol Oncol       Date:  2008-12-24       Impact factor: 6.603

10.  Somatic APC inactivation mechanisms in sporadic colorectal cancer cases in Hungary.

Authors:  Eniko Kámory; Judit Olasz; Orsolya Csuka
Journal:  Pathol Oncol Res       Date:  2008-03-28       Impact factor: 3.201

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.